← SynDRA
SYN0045335
SynDRA canonical compound SYN0045335 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AURKA | AURKB | AURKC | MAP2K1 | MAP2K2 |
|---|
| Mechanism of action | Aurora kinase inhibitor | MEK inhibitor |
|---|
All known targets
- AURKA
- AURKC
- LATS1
- MAP2K1
- MAP2K2
Mechanisms of action (all sources)
- AURKA INHIBITOR
- AURKC INHIBITOR
- LATS1 INHIBITOR
- MAP2K1 INHIBITOR
- MAP2K2 INHIBITOR
Cross-references
Synonyms
- BI 847325
- QXD8ZW7UVZ
- BI847325
- C29H28N4O2
- 5U5
- UNII-QXD8ZW7UVZ
- orb1300468
- SCHEMBL4081822
- SCHEMBL10326049
- SCHEMBL26907228
- SCHEMBL29355149
- SCHEMBL30197784
- GTPL12661
- BDBM142744
- EX-A1727
- HYB29336
- MFCD28978743
- NSC799360
- s7843
- AKOS026674081
- AKOS030238788
- CCG-269395
- CS-6291
- EBC-220040
- NSC-799360
- SB23246
- NCGC00481575-01
- NCGC00481575-03
- AC-29870
- AS-56076
- HY-18955
- BI-847325?
- T6785
- US8937095, 6
- BRD-K37492701-001-01-1
- BRD-K37492701-001-02-9
- BI-847325; BI 847325; BI847325
Look up SYN0045335 in the interactive SynDRA portal →